Home
About
FAQ
History (11)
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
HCV proteins increase expression of heme oxygenase-1 (HO-1) and decrease expression of Bach1 in human hepatoma cells.
MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection.
Genetic variations in heme oxygenase-1 and chronic hepatitis.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic variations in heme oxygenase-1 and chronic hepatitis.
Bonkovsky HL, Lambrecht RW, Naishadham D. Genetic variations in heme oxygenase-1 and chronic hepatitis. Hepatology. 2010 Jul; 52(1):400-1.
View in:
PubMed
subject areas
Antiviral Agents
Continental Population Groups
Gene Expression Regulation, Enzymologic
Genetic Variation
Heme Oxygenase-1
Hepatitis C, Chronic
Humans
Prognosis
Promoter Regions, Genetic
Treatment Outcome
United States
authors with profiles
Herbert L. Bonkovsky MD